These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9032533)

  • 21. Renal cell carcinoma extending to the renal vein and inferior vena cava: results of surgical treatment and prognostic factors.
    Tongaonkar HB; Dandekar NP; Dalal AV; Kulkarni JN; Kamat MR
    J Surg Oncol; 1995 Jun; 59(2):94-100. PubMed ID: 7776659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal cell carcinoma and tumour thrombus in the inferior vena cava: clinical outcome of 98 consecutive patients and the prognostic value of preoperative parameters.
    Niedworok C; Dörrenhaus B; Vom Dorp F; Piotrowski JA; Tschirdewahn S; Szarvas T; Rübben H; Schenck M
    World J Urol; 2015 Oct; 33(10):1541-52. PubMed ID: 25433505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal vein and vena cava involvement does not affect prognosis in patients with renal cell carcinoma.
    Ficarra V; Righetti R; D'Amico A; Rubilotta E; Novella G; Malossini G; Mobilio G
    Oncology; 2001; 61(1):10-5. PubMed ID: 11474242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.
    Tilki D; Hu B; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chandrasekar T; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Linares E; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Thieu W; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
    J Urol; 2015 Feb; 193(2):436-42. PubMed ID: 25063493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Venous tumor invasion by renal cell carcinoma. Surgical technique, complications and survival rate].
    Gschwend J; Maier S; Flohr P; de Petriconi R; Hautmann RE
    Urologe A; 1994 Sep; 33(5):440-6. PubMed ID: 7974934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
    Blute ML; Amling CL; Bryant SC; Zincke H
    Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?
    Kim HL; Zisman A; Han KR; Figlin RA; Belldegrun AS
    J Urol; 2004 Feb; 171(2 Pt 1):588-91. PubMed ID: 14713765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases.
    Ficarra V; Righetti R; Martignoni G; D'Amico A; Pilloni S; Rubilotta E; Malossini G; Mobilio G
    Urol Int; 2001; 67(2):130-4. PubMed ID: 11490206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
    Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
    J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.
    Abel EJ; Spiess PE; Margulis V; Master VA; Mann M; Zargar-Shoshtari K; Borregales LD; Sexton WJ; Patil D; Matin SF; Wood CG; Karam JA
    J Urol; 2017 Aug; 198(2):281-288. PubMed ID: 28268170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.
    Bazzi WM; Sjoberg DD; Feuerstein MA; Maschino A; Verma S; Bernstein M; O'Brien MF; Jang T; Lowrance W; Motzer RJ; Russo P
    J Urol; 2015 Jun; 193(6):1911-6. PubMed ID: 25524244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.
    Sun M; Bianchi M; Hansen J; Abdollah F; Trinh QD; Lughezzani G; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    Int J Urol; 2013 Apr; 20(4):372-80. PubMed ID: 23039208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.
    Lambert EH; Pierorazio PM; Shabsigh A; Olsson CA; Benson MC; McKiernan JM
    Urology; 2007 Jun; 69(6):1054-8. PubMed ID: 17572185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
    Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
    J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical treatment of renal cell carcinoma: Can morphological features of inferior vena cava tumor thrombus on computed tomography or magnetic resonance imaging be a prognostic factor?
    Choi DK; Jeon HG; Jeong CW; Kwak C; Song C; Chung J; Hong SK; Hong SH; Seo SI;
    Int J Urol; 2017 Feb; 24(2):102-109. PubMed ID: 28111837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reassessing the current TNM lymph node staging for renal cell carcinoma.
    Terrone C; Cracco C; Porpiglia F; Bollito E; Scoffone C; Poggio M; Berruti A; Ragni F; Cossu M; Scarpa RM; Rossetti SR
    Eur Urol; 2006 Feb; 49(2):324-31. PubMed ID: 16386352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-operative risk stratification for cancer-specific survival in patients with renal cell carcinoma with venous involvement who underwent nephrectomy.
    Nakayama T; Saito K; Fujii Y; Abe-Suzuki S; Nakanishi Y; Kijima T; Yoshida S; Ishioka J; Matsuoka Y; Numao N; Koga F; Kihara K
    Jpn J Clin Oncol; 2014 Aug; 44(8):756-61. PubMed ID: 24872404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical management and prognosis of renal cell carcinoma invading the vena cava.
    Hatcher PA; Anderson EE; Paulson DF; Carson CC; Robertson JE
    J Urol; 1991 Jan; 145(1):20-3; discussion 23-4. PubMed ID: 1984092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma.
    Capitanio U; Matloob R; Suardi N; Abdollah F; Castiglione F; Di Trapani D; Russo A; Briganti A; Carenzi C; Salonia A; Montorsi F; Rigatti P; Bertini R
    Urologia; 2012; 79(2):109-15. PubMed ID: 22610843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical Management and Outcome of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus.
    Berczi A; Flasko T; Szerafin T; Thomas B; Bacso Z; Berczi C
    Urol Int; 2017; 99(3):267-271. PubMed ID: 28253496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.